Randomised, Double Blind, Placebo Controlled Trial to Ascertain the Efficacy and Safety of Intravenous Zoledronic Acid in Adult Patients With Cystic Fibrosis.
Status: Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 23 Oct 2015
Price : $35 *
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Cystic fibrosis
- Focus Therapeutic Use
- Acronyms IZAC
- 23 Sep 2013 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 01 Jul 2013 New trial record